Literature DB >> 16830230

Water-soluble formulation of Coenzyme Q10 inhibits Bax-induced destabilization of mitochondria in mammalian cells.

Jafar Naderi1, Mallika Somayajulu-Nitu, Amit Mukerji, Priya Sharda, Marianna Sikorska, Henryk Borowy-Borowski, Bruno Antonsson, Siyaram Pandey.   

Abstract

Oxidative stress leads to mitochondrial dysfunction, which triggers the opening of the permeability transition pores (PTP) and the release of pro-apoptotic factors causing apoptotic cell death. In a limited number of cell systems, anti-oxidants and free-radical scavengers have been shown to block this response. We have previously reported that coenzyme Q(10) (CoQ(10)), an electron carrier in the mitochondrial respiratory chain, is involved in the reactive oxygen species (ROS) removal and prevention of oxidative stress-induced apoptosis in neuronal cells. However, the mechanism of this protection has not been fully elucidated. In the present study we investigated the effects of CoQ(10) on the mitochondrial events characteristic to apoptosis, especially on the function of pro-apoptotic protein Bax. Our results demonstrated that following a brief exposure of two human cell lines (fibroblasts and HEK293 cells) to H(2)O(2) the intracellular levels of ROS and the association of Bax with the mitochondria significantly increased and the cells underwent apoptosis. Both of these events, as well as the release of cytochrome c from the mitochondria, were blocked by a 24 h pre-treatment with CoQ(10). It is therefore believed that CoQ(10) prevented the collapse of the mitochondrial membrane potential in response to the H(2)O(2) treatment. Recombinant Bax protein alone caused the ROS generation and release of cytochrome c from isolated mitochondria and, again, CoQ(10) inhibited these Bax-induced mitochondrial dysfunctions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16830230     DOI: 10.1007/s10495-006-8417-4

Source DB:  PubMed          Journal:  Apoptosis        ISSN: 1360-8185            Impact factor:   4.677


  22 in total

1.  Mitochondrial therapies for Parkinson's disease.

Authors:  Bobby Thomas; M Flint Beal
Journal:  Mov Disord       Date:  2010       Impact factor: 10.338

Review 2.  The role of autophagy in Parkinson's disease.

Authors:  Melinda A Lynch-Day; Kai Mao; Ke Wang; Mantong Zhao; Daniel J Klionsky
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

3.  Maternal antioxidants prevent β-cell apoptosis and promote formation of dual hormone-expressing endocrine cells in male offspring following fetal and neonatal nicotine exposure.

Authors:  Jennifer E Bruin; Amanda K Woynillowicz; Bart P Hettinga; Mark A Tarnopolsky; Katherine M Morrison; Hertzel C Gerstein; Alison C Holloway
Journal:  J Diabetes       Date:  2012-09       Impact factor: 4.006

4.  Reversal of oxidative stress-induced apoptosis in T and B lymphocytes by Coenzyme Q10 (CoQ10).

Authors:  Sastry Gollapudi; Sudhir Gupta
Journal:  Am J Clin Exp Immunol       Date:  2016-04-27

Review 5.  Mitochondrial approaches for neuroprotection.

Authors:  Rajnish K Chaturvedi; M Flint Beal
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

6.  Nanomicellar formulation of coenzyme Q10 (Ubisol-Q10) effectively blocks ongoing neurodegeneration in the mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model: potential use as an adjuvant treatment in Parkinson's disease.

Authors:  Marianna Sikorska; Patricia Lanthier; Harvey Miller; Melissa Beyers; Caroline Sodja; Bogdan Zurakowski; Sandhya Gangaraju; Siyaram Pandey; Jagdeep K Sandhu
Journal:  Neurobiol Aging       Date:  2014-04-02       Impact factor: 4.673

7.  Paraquat induces oxidative stress, neuronal loss in substantia nigra region and parkinsonism in adult rats: neuroprotection and amelioration of symptoms by water-soluble formulation of coenzyme Q10.

Authors:  Mallika Somayajulu-Niţu; Jagdeep K Sandhu; Jerome Cohen; Marianna Sikorska; T S Sridhar; Anca Matei; Henryk Borowy-Borowski; Siyaram Pandey
Journal:  BMC Neurosci       Date:  2009-07-27       Impact factor: 3.288

Review 8.  Bcl-2 family proteins as regulators of oxidative stress.

Authors:  Nathan Susnow; Liyun Zeng; Daciana Margineantu; David M Hockenbery
Journal:  Semin Cancer Biol       Date:  2008-12-24       Impact factor: 15.707

Review 9.  Mitochondrial medicine for neurodegenerative diseases.

Authors:  Heng Du; Shirley ShiDu Yan
Journal:  Int J Biochem Cell Biol       Date:  2010-01-11       Impact factor: 5.085

Review 10.  Primary coenzyme Q10 (CoQ 10) deficiencies and related nephropathies.

Authors:  Fatih Ozaltin
Journal:  Pediatr Nephrol       Date:  2013-06-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.